Skip to search formSkip to main contentSkip to account menu

MK-8141

Known as: ACT-077825 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Background/Aims: The study objective was to investigate and compare the pharmacokinetics of a single oral dose of ACT-077825, a… 
2013
2013
Abstract: This study was conducted to characterize the multiple-dose tolerability, pharmacokinetics, and pharmacodynamics of ACT… 
2013
2013
This open‐label, randomized study evaluated the effects of steady‐state diltiazem on the pharmacokinetic, safety, and… 
2012
2012
To evaluate the pharmacokinetics, pharmacodynamics, safety, and tolerability of escalating single oral doses of ACT-077825, a… 
2010
2010
2009
2009
(+)-Dapoxetine hydrochloride; Abatacept, Adalimumab, Agalsidase beta, Alemtuzumab, Alglucosidase alfa, Aliskiren fumarate…